Benefit of 5 years of enzyme replacement therapy in advanced late onset Pompe. A case report of misdiagnosis for three decades with acute respiratory failure at presentation

MLA

Mandat Maharaj, et al. “Benefit of 5 Years of Enzyme Replacement Therapy in Advanced Late Onset Pompe. A Case Report of Misdiagnosis for Three Decades with Acute Respiratory Failure at Presentation.” Molecular Genetics and Metabolism Reports, vol. 32, no. 100896-, Sept. 2022. EBSCOhost, https://doi.org/10.1016/j.ymgmr.2022.100896.

APA

Mandat Maharaj, David L. Skidmore, Sidney E. Croul, David J. Brake, & Hanns Lochmuller. (2022). Benefit of 5 years of enzyme replacement therapy in advanced late onset Pompe. A case report of misdiagnosis for three decades with acute respiratory failure at presentation. Molecular Genetics and Metabolism Reports, 32(100896-). https://doi.org/10.1016/j.ymgmr.2022.100896

Chicago

Mandat Maharaj, David L. Skidmore, Sidney E. Croul, David J. Brake, and Hanns Lochmuller. 2022. “Benefit of 5 Years of Enzyme Replacement Therapy in Advanced Late Onset Pompe. A Case Report of Misdiagnosis for Three Decades with Acute Respiratory Failure at Presentation.” Molecular Genetics and Metabolism Reports 32 (100896-). doi:10.1016/j.ymgmr.2022.100896.